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1. Introduction 
Bicuspid aortic valve (BAV) disease is the most common congenital cardiac abnormality, 
occurring in 0.5% to 2% of the general population (Ward, 2000; Braverman et al., 2005), and 
in 0.9% as reported in autopsy studies (Roberts, 1970). It may be sporadic or familial and 
sporadically transmitted through families by an autosomal dominant pathway with a 4:1 
male predominance (Cripe et al., 2004). The BAV may be associated with significant valvular 
dysfunction (Ward, 2000), will develop aortic stenosis and regurgitation, and will be at risk 
for infective endocarditis (Braverman et al., 2005; Sabet et al., 1999). The bicuspid valve 
includes different morphologic phenotypes (Sabet et al., 1999; Fernandes et al., 2004). It 
usually consists of two cusps unequal in size. The cusps are typically oriented right to left, 
and the larger cusp has a central raphe or ridge (Sievers & Schmidtke, 2007). Notably, 
pathologic examination of the raphe could not be demonstrated containing the valve tissue 
(Pomerance, 1972). A review of the echocardiograms of 1135 children with BAV revealed 
that the most common morphologic pattern is the fusion of the right and left cusps in 70% of 
all patients (Fernandes et al., 2004). Sievers & Schmidtke (2007) also reported that 71% of 304 
BAV surgical specimens had right and left leaflet fusion. Raphal position was described 
between the right and left cusps in 86% of cases in surgical pathology study reported by 
Sabet et al (1999). Previously, much of the original focus centered on the abnormal bicuspid 
valve. Actually, BAV is not just only a disorder of valvulogenesis, but is also a coexistent 
genetic disorder of the aorta (Siu & Silversides, 2010). More recent studies have shown that 
structural abnormalities occur at the cellular level. The structural abnormalities of the 
thoracic aorta disclose a deficiency of fibrillin-1, increased activity of matrix 
metalloproteinases (MMPs), elastin fragmentation, and vascular smooth muscles cell 
(VSMC) apoptosis (Tadros et al., 2009). Genetic studies have reported that BAV is likely due 
to mutations in different genes with dissimilar patterns of inheritance (Cripe et al., 2004; Siu 
& Silversides, 2010). Typically, mutation in the NOTCH1 gene leads to signaling 
abnormalities, which may be responsible for abnormal development of the aortic valve, and 
later to accelerated valvular calcium deposition (Garg et al., 2005; Mohamed et al., 2006). 
In patients with BAV, the presence of BAV is an important risk factor for progressive 
dilatation of the aortic root and ascending aorta, even in BAV patients with normal valvular 
function (Nkomo et al., 2003; Gurvitz et al., 2004; Warren et al., 2006). Thus, because of its 
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frequent association with aortic dilatation, BAV may predispose an individual to aortic 
dissection or rupture. Based on these findings, valve function as well as the diameter of 
aortoventricular annulus, sinuses of Valsalva, sinotublar junction, and ascending aorta 
should periodically checked (Tadros et al., 2009). In addition, the current American College 
of Cardiology (ACC)/American Heart Association (AHA) adult congenital heart disease 
guidelines suggest that echocardiographic screening for BAV in the first-degree relatives of 
BAV patients is necessary (Warnes et al., 2008). 
2. Surgical treatment of valve pathology 
Although the clinical presentation of BAV can vary from a benigh condition, often 
undetected throughout life, to severe valve disease in infancy (Fenoglio et al., 1977; Siu & 
Silversides, 2010), it is typically associated with aortic valve dysfunction in adulthood 
(Brown et al., 2007; Siu & Silversides, 2010). The common valve dysfunctions include 
stenosis, regurgitation, and endocarditis. Up to 85% of patients with BAV have aortic 
stenosis after the fifth decade of life (Sabet et al., 1999; Ashikhmina et al., 2010). In contrast, a 
pure aortic regurgitation (AR) is less common, develops in approximately 20% of patients 
with BAV, and usually manifests earlier in life than aortic stenosis (Sabet et al., 1999; 
Ashikhmina et al., 2010). These patients are typically treated with valvular surgery, often 
during the third and fourth decade of life (Sabet et al., 1999; Casselman et al., 1999; Ward, 
2000; Badiu et al., 2011). Because the population of BAV patients is relatively young, in these 
young patients the choice of an appropriate heart valve substitute is difficult. The optimal 
substitute should be durable and have a minimal effect on quality of life and longevity 
(Schafers et al., 2007; Ashikhmina et al., 2010). 
2.1 Balloon valvuloplasty 
Percutaneous balloon valvuloplasty was first described in 1983 (Labobidi, 1983), and the 
effectiveness of this method, as well as the low incidence of restenosis shortly after the 
procedure, was first documented in children with congenital aortic stenosis (Labobidi et al., 
1984) and then in a newborn with critical aortic stenosis (Labobidi & Weinhous, 1986). 
During childhood, valve replacement for the stenotic bicuspid valve is suboptimal because 
of the continuing growth of the child (Siu & Silversides, 2010). Therefore, in the current era, 
surgical valvotomy has been replaced by balloon valvuloplasty, which has become the 
procedure of choice in many centers for the treatment of critically ill infants with a severely 
stenotic aortic valve (Vida et al., 2005) because it has generally been reported to be a 
relatively low-risk procedure with reasonable short-term results (Mahle et al., 2010). At the 
University of Padova, (Padua, Italy), critical aortic stenosis in early infancy has been treated 
routinely with primary balloon valvuloplasty with a low early mortality (2.9%) and a low 
incidence of complications (2.9%) (Vida et al., 2005). Moreover, valvuloplasty is the 
interventional strategy of choice in children and in some young adults with BAV and aortic 
stenosis, because the aortic valve is usually not calcified at this stage and, therefore, the 
commissural adhesion can be successfully disrupted and the stenotic valve lesion relieved 
(Siu & Silversides, 2010). Nevertheless, incomplete relief of the valvar stenosis and 
significant AR are well-documented after percutaneous balloon valvuloplasty (Bacha et al., 
2001). Mid-term results have shown a substantial incidence of restenosis, severe AR, and 
reintervention (Moore et al., 1996). Reich et al. (2004) demonstrated that a small aortic 
annulus and BAV were independent predictors of an unfavourable outcome. In such a 
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situation, patients with hypoplastic annuli and functional bicuspid valves may be primarily 
considered for surgery in order to prevent the risk of aortic regurgtation and the need for 
valve replacement (Reich et al., 2004). 
Actually, any type of treatment for aortic stenosis in newborns and infants is palliative, and 
future aortic valve replacement is inevitable (Vida et al., 2005). Because the bioprosthetic 
valve has a high structural failure rate in young patients and mechanical valves have a risk 
of anticoagulant-related morbidity, the better option of aortic valve substitute in infants and 
children is the pulmonary autograft because of its potential for growth (Vida et al., 2005; 
Behery et al., 2009). 
2.2 Aortic valve replacement 
As outlined in the 2006 American College of Cardiology/American Heart Association 
Guidelines for the Management of Patients With Valvular Heart Disease (Bonow et al., 
2006), aortic valve repair involves a lack of uniform applicability and lack of widespread 
experience with surgical techniques. Moreover, there are no clear indications on when repair 
should be performed and the regarding data demonstrating its safety and durability are 
limited (Rao et al., 2000; EI Khoury et al., 2006; Aicher et al., 2007; Ashikhmina et al., 2010). 
In adulthood, the major implication associated with BAV is a tendency toward premature 
degeneration of the aortic valve with premature presentation of calcific valvular stenosis 
(Braverman et al., 2005). If aortic valve repair is impossible because of the remarkable 
structural changes of the aortic valve, the definitive surgical treatment is aortic valve 
replacement (AVR) (Ali et al., 2010). AVR for aortic valve stenosis is the second most 
common reason for cardiac surgery in the industrialized countries, and BAV is the second 
most common cause of aortic valve disease requiring surgery (Etz et al., 2007). 
In patients with congenital aortic valve disease such as BAV, Klieverik et al. (2008) reported 
that the durability of allografts for aortic valve replacement is better than that of 
bioprostheses, and that their hemodynamic profile is superior to that of mechanical 
prostheses and bioprostheses. However, the increasing reoperation risk within ten to twenty 
years remains a major concern. Wijesinghe et al. (2010) proved that transcatheter aortic 
valve implantation (TAVI) in selected high-risk patients with severe BAV stenosis can be 
successfully performed with acceptable early clinical outcomes, but that its long-term 
durability will require further evaluation. On the contrary, Zegdi et al. (2008a) proposed that 
the valvular opening shape tends to be elliptical rather than circular in patients with BAV; 
elliptical deployment of valved stents will inevitably create valve distortion that may 
impede their long-term durability. Thus, BAV stenosis has been considered a questionable 
indication or even a contraindication for endovascular valve implantation (Zegdi et al., 
2008a; Zegdi et al., 2008b). 
2.3 Ross procedure 
Ross (1967) first described replacement of the diseased aortic valve by pulmonary autograft 
in 1967, and the full root technique with a pulmonary autograft was introduced in 1989 
(Stelzer et al., 1989). The Ross operation is an acceptable alternative to conventional aortic 
valve replacement and has been shown to provide excellent hemodynamic results. The 
advantages of this therapeutic option are the use of a viable autologous valve and a low 
incidence of infection and thrombogenicity, avoidance of anticoagulant therapy, as well as 
its potential to grow in children (Hanke et al., 2007; Brown et al., 2010; Sievers et al., 2010; 
Ryan et al., 2011). Nevertheless, there is growing concern about autograft failure and 
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surgical revisions because of the frequently concomitant aortic root and tubular ascending 
aorta pathology observed in many patients with BAV (Hanke et al., 2010), and the intrisic 
abnormalities in the wall of the pulmonary artery based on the common embryological 
origin of the aortic and pulmonary root, which may contribute to progressive neoaortic root 
dilatation and AR, or both, when the pulmonary root is placed in the systemic position 
(David et al., 2000; Siu & Silversides, 2010; Hanke et al., 2010). 
Progressive dilatation of the pulmonary autograft with or without regurgitation of the 
autograft valve is a common indication of reoperation (David et al., 2000; Luciani et al., 2003; 
Takkenberg et al., 2006; Hanke et al., 2007; Ozaslan et al., 2009; Aljassim et al., 2011). In 
addition, factors contributing to a limited acceptance are the complexity of the operation 
and a dearth of long-term clinical information on the durability of the autograft in the aortic 
position and the durability of the pulmonary conduit substitute (Sievers et al., 2010). This 
concern has led many to reconsider the indication for the Ross operation in the adult 
population for whom other surgical options are available (Hanke et al., 2007; David, 2009). 
There are even some do not advocate the use of the Ross operation in patients with BAV 
disease (Siu & Silversides, 2010). Nevertheless, freedom from autograft or pulmonary 
conduit reoperation was 89% at 10-year follow-ups reported from the German-Dutch 
Registry (Sievers et al., 2010). They concluded that the autograft procedure is a valuable 
therapeutic option for treating aortic valve disease (including BAV) in children, adolescents, 
and young adults (Sievers et al., 2010). Recently, Ryan et al. (2011) reported that freedom 
from pulmonary autograft reoperation for aortic stenosis patients was 95% at 10 years. They 
concluded that the Ross procedure in adults provides excellent freedom from autograft 
failure in patients operated for aortic stenosis. Conversely, the freedom from autograft 
reoperation rate was 67% at 10 years in patients with AR preoperatively. Thus, the Ross 
operation provided suboptimal results in patients with aortic insufficiency (David et al., 
2010; Ryan et al., 2011). Therefore, other therapeutic alternatives should be strongly 
considered in adults presenting primarily with aortic inssuffciency (Ryan et al., 2011). 
Pulmonary autograft dilatation is common after the Ross procedure in adults, and this 
might be a cause of reoperation (David et al., 2000; Aljassim et al., 2011). Patients with BAV 
and dilated ascending aortas, or patients with dilated aortic root and primarily AR, have 
been considered the highest-risk groups for dilatation and neo-aortic valvular regurgitation 
(Tantengco et al., 1999; Simon-Kupilik et al., 2002; Kouchoukos et al., 2004; Brown et al., 
2010). Perhaps the modified Ross procedure, as described by Ungerleider et al., in which the 
autograft is completely encased in a Dacron graft before implantation, may provide better 
results in patients with preoperative ascending aortic and sinus dilation. A long-term 
follow-up for successful valve function will be needed for this technique to be 
recommended for wider use (Ungerleider et al., 2010). 
In summary, although the early outcomes continue to be excellent, follow-ups after more 
than 10 years show continued deterioration of the autografts and a need for reoperation in a 
substantial percentage of patients, particularly those in whom the root replacement 
technique was used. Thus, some investigators suggested that the Ross procedure should not 
routinely be used for aortic valve replacement in adults (Kouchoukos, 2011). 
2.4 Repair of regurgitant valve 
Clinically, up to 15% to 20% of patients with BAV are reported to have had significant AR as 
young or middle-aged adults (Roberts, 1970; Olson et al., 1984; Ward, 2000). Although 
chronic AR is well tolerated for a long time, progressive left ventricular dilatation is a sign 
www.intechopen.com
 
Surgical Treatment of Bicuspid Aortic Valve Disease 
 
335 
with ominous results if timely intervention is not undertaken (Pretre et al., 2006). This 
makes the choice of valve substitutes difficult because of the limitations of current 
prostheses. Mechanical valves have an excellent freedom from reoperation, but the cumulative 
risk of thromboembolic complications and anticoagulation-related hemorrhage may be 
substantial due to the long exposure time (Khan, 2002; Salem et al., 2004). The Ross procedure 
is ideal for young patients with BAV stenosis because of its low operative mortality, excellent 
hemodynamic performance, low prevalence of infection, avoidance of anticoagulant therapy, 
and potential to grow in children (El Behery et al., 2009; Takkenberg et al., 2009). However, 
the presence of preoperative AR and aortic root dilatation are important independent 
determinants of reoperation for pulmonary autograft failure (Elkins et al., 2008; de Kerchove 
et al., 2009; Ryan et al., 2011). For these reasons, repairing the BAV is an attractive 
therapeutic option (Ashikhmina et al., 2010; Boodhwani et al., 2011; Ryan et al., 2011). 
Reconstruction of the regurgitant bicuspid valve was proposed as early as 1991 by Cosgrove 
et al. (1991). Subsequently, others have been able to reproduce reconstructive surgery for 
regurgitant BAV with good results (Aicher et al., 2004); although some others who used the 
Cosgrove technique proposed that the intraoperative results were rarely predictable and 
that there was a high reoperation rate in the early phase (Moidl et al., 1995). 
Cusp prolapse may be an isolated cause of AR or may exist in conjunction with dilatation of 
the proximal aorta. Prolapse can be corrected by central plication, triangular resection, or 
pericardial patch implantation (Aicher et al., 2007b). In the case of limited cusp prolapse, 
Aicher et al. (2007b) used plication stitches in the central portion of the free edge of the cusp, 
which were possibly first used by Spencer et al. (1962). The concept of paracommissural 
plication has been used in AR with ventricular septal defects (Starr et al., 1960; Garamella et 
al., 1960). Aicher et al. (2007b) showed that central plication had better valve stability with 
freedom from recurrent AR and freedom from reoperation at 10 years postoperatively 
compared with the paracommissural approach. In the presence of a more extensive 
prolapse, a triangular resection was adopted to avoid excessive bulging of plicated cusp 
tissue (Aicher et al., 2007b). The reason for their low failure rate may be that they frequently 
corrected prolapse of both cusps in bicuspid aortic valves. On the other hand, using 
pericardial patch augmentation to close congenital fenestrations that had led to increase 
coaptation surface provides reliable early and midterm competence of reconstructed 
bicuspid aortic valves (Aicher et al., 2007b; Doss et al., 2008). 
The systemic segmental approach suggested by Pettersson et al. (2008) is based on 
echocardiographic evaluation. Their findings emphasized that restrictive cusp motion, due 
to fibrosis or calcification, is an important predictor for recurrent AR following valve repair. 
On the contrary, redundant or sufficient cusp tissue offers a greater potential for 
reparability. Several studies have suggested risk factors for failure of BAV repair. Casselman 
et al. (1999) described left ventricular dysfunction as a predictor of immediate, persistant 
regurgitation after valve repair. Nash et al. (2005) reported that the paramenters included an 
eccentric jet of AR, absence of cuspal or commissural thickening, and lack of cusp 
calcification associated with an increased likelihood of successful valve repair. De Kerchove 
et al. (2008) suggested that methods of repair of the prolapsed cusp and increased left 
ventricular end-diastolic diameter were predictors of BAV repair failure. Recently, the size 
of the aortoventricular junction was also shown to be an independent risk factor for 
recurrence of regurgitation after repair (Aicher et al., 2011). One should be hesitant to repair 
a BAV if the aortoventricular diameter is ≥ 29mm, if commissural orientation is < 160°, and 
if a pericardial patch is required for partial cusp replacement (Aicher et al., 2011). 
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In summary, bicuspid aortic valve repair is a viable alternative to replacement with a 
bioprosthesis because durability and safety are similar between both surgical management 
methods for AR. Nevertheless, after initial repair, approximately half of the patients require 
aortic valve replacement within 10 years (Ashikhmina et al., 2010). 
3. Surgical treatment of bicuspid aortic valve with aortopathy 
Studies on children (Beroukhim et al., 2006; Warren et al., 2006; Holmes et al., 2007) and 
adults (Yasuda et al., 2003; Davies et al., 2007; Tadros et al., 2009) have reported significantly 
faster aortic dilatation in the significantly younger with BAV versus trileaflet aortic valve 
(Figure). BAV is associated with ascending aortic dilatation and enlargement of the aortic 
root annulus in as many as half of all individuals (Nkomo et al., 2003; Park et al., 2011). 
Therefore, the size and shape of the ascending aorta should be serially followed. 
Measurements of the aortic root dimensions should be performed at the level of the 
ventriculoaortic diameter, sinuses of Valsalva, sinotubular junction, and proximal ascending 
aorta (Braverman et al., 2005). Surgery to repair the aortic root or replace the ascending aorta 
has been recommended for those patients with dilated aortic roots or ascending aortas, with 
possible early prophylactic surgical intervention to prevent dissection or rupture (Bonow et 
al., 2008; Tadros et al., 2009). 
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Reprinted from Beroukhim et al. (2006), with permission from Elsevier. Copright 2006. 
Fig. 1. Measurements of the ascending aorta in centimeters for patients with BAVs (n = 101) 
and controls (n = 97). The upper slope (circles) represents the BAV group, and the lower 
slope (triangles) represents the control group. Regression equations are in the same order  
(y = 0.0151x = 0.2926; y = 0.0117x + 0.362). Measurements and height are expressed in 
centimeters 
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3.1 Valve sparing aortic root replacement 
Valve-sparing aortic root replacements are becoming more popular in view of the potential 
thromboembolic, and infection complications after composite graft replacement (Cozijnsen 
et al., 2011). Currently, there are two different techniques of valve-sparing root replacement. 
In the remodeling technique of the aortic root described by Sarsam and Yacoub (1993), the 
graft is sewn to the remaining aortic wall around the commissures. In the reimplantation 
technique proposed by David and Feindel (1992), the graft is fixed at the subannular level, 
and the valve and commissures are reimplanted inside the graft. Both procedures provide 
an alternative to composite root replacement with excellent short- and medium-term results, 
but the long-term durability is not yet established (Cozijnsen et al., 2011). Of note, the main 
limitation of valve-sparing procedures compared with aortic root replacement with a 
composite graft remains the predominant risk for reoperation on the bicuspid aortic valve 
due to recurrent regurgitation (Zehr et al., 2004; Badiu et al., 2010). Cattaneo et al. (2004) 
reported that late results with valve-sparing procedure in children have been compromised 
by late root dilatation. Kallenbach et al. (2002) reported that some of their patients 
subsequently required valve replacement after valve-sparing operations because of 
subsequent increases in AR. On the contrary, Badiu et al. (2010) said that root replacement 
with aortic valve-sparing should be offered even in the presence of a BAV or severe AR. 
Aicher et al. (2007a) reported that remodeling of the aortic root can be treated in patients 
with dilatation of the aortic root and concomitant AR whenever the aortoventricular 
junction was not dilated. Freedom from reoperation was 96% at 5 and 10 years, and freedom 
from valve replacement was 98% at 5 and 10 years. Thus, they concluded that root 
remodeling leads to durable restoration of bicuspid valve function and that the risk of 
reoperation is low. Therefore, root remodeling is a good option in patients with aortic 
dilatation and AR undergoing valve-sparing aortic replacement (Aicher et al., 2007a). 
Cusp pathology is frequently encountered in patients with supracoronary ascending aortic 
aneurysm and AR. Severe AR is not a contraindication to valve-sparing surgery, but careful 
identification and repair of cusp pathology, in addition to sinotubular junction reduction, is 
critical for durable, long-term outcome (Boodhwani et al., 2011). There is no actual 
recommendation in the ACC/AHA guidelines for valve-sparing aortic root replacement 
(Bonow et al., 2006). The guidelines indicate that this may be possible in selected patients for 
valve-sparing procedures at experienced centers when there is no AR or deformed or 
calcified aortic valves (Bonow, 2008). Despite reports of good mid-term results with valve-
sparing operations (Doss et al., 2010; De Paulis et al., 2010), some experts believe that 
leaving behind the abnormal BAV is ill-advised. Therefore, the optimal surgical approach 
for patients with BAV remains to be defined (Siu & Silverslides, 2010). 
3.2 Ascending aorta replacement 
It is now widely accepted that an inherent aortopathy exists regardless of whether the valve 
has any functional abnormalities. Ascending aortic dilatation occurs more frequently and at 
a younger age in patients with a BAV than in patients with a tricuspid aortic valve (Hahn et 
al., 1992; Nkomo et al., 2003), and, according to Yasuda et al. (2003), the aorta continues to 
dilate, even after valve replacement. Because of this, reoperation for aortic aneurysm as well 
as late aortic dissection and sudden rupture are significantly higher in this group of patients 
(Russo et al., 2002; Borger et al., 2004). Although the proximal ascending aorta is thought to 
be the most commonly affected segment (Nkomo et al., 2003; Alegret et al., 2003; Westhoff-
Bleck et al., 2005; Tadros et al., 2009; Biner et al., 2009), recent computed tomographic 
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angiography or magnetic resonance angiography and echocardiography studies of the 
thoracic aorta morphology in patients with BAV show more diffuse and distinct patterns of 
aortopathy extending from the aortic root to the proximal aortic arch (Westhoff-Bleck et al., 
2005; Fazel et al., 2008; Nazer et al., 2010). 
The two main theories explaining the phenomenon of aortopathy in patients with BAV are: 
(1) the genetic theory, and (2) the hemodynamic theory. Both genetic and hemodynamic 
causes of aortic pathology associated BAV have been postulated, and there is still a great 
deal of controversy about the pathogenesis of the dilatation of the ascending aorta. Given 
the marked heterogeneity of BAV disease, further studies are required in order to more 
accurately determine which theory is the correct one for explaining BAV-derived aortopathy 
(Bonow et al., 2008; Tadros et al., 2009; Girdauskas et al., 2011). 
Looking at the time of rupture or dissection on a lifetime basis, it can be seen that there are 
sharp hinge points when the ascending aorta reaches 6 cm in diameter (i.e., the patient has 
incurred a 34% risk of rupture or dissection) (Elefteriades & Farkas, 2010). The mortality rate 
for elective surgical correction of ascending aortic aneurysm in an experienced center is 2.5% 
to 5.0% (Elefteriades, 2002; Isselbacher, 2005; Tadros et al., 2009). Ascending aortic 
aneurysms with an annual risk of rupture or dissection higher than the combined risks of 
perioperative mortality should be repaired electively (Tadros et al., 2009). These data permit 
evidence-based criteria for surgical intervention. Because rupture or dissection occurs at 6 
cm or more, most adverse events can be prevented by operating at a criterion of less than 6 
cm (Elefteriades, 2010). Therefore, for idiopathic ascending aortic aneurysms, surgical 
intervention at up to 5.5 cm has been recommended on the basis. In contrast, to 
accommodate differences in body size for optimal operative decision making, Elefteriades 
(2002) proposed using the aortic size indexed to body mass, rather than using absolute aortic 
dimensions to predict risk. In other words, adults with small body size should undergo 
earlier intervention because a higher ratio of aortic size to body size is a predictor of 
increased risk (Svensson & Khitin, 2002; Svensson et al., 2003; Davies et al., 2006; Tadros et 
al., 2009). The risk of rupture, dissection, or death is high (approximately 20% per year) 
when the aortic size index is above 4.25 cm/m2 (Davies et al., 2006). However, an aorta less 
than 5 cm in diameter does not guarantee freedom form aortic complications. Autopsies and 
clinical studies have shown that aortic dissection certainly occurs in near-normal-sized 
aortas that do not fall within current guidelines for elective aneurysm surgery (Neri et al., 
2005; Pape et al., 2007; Bajona et al., 2010). 
Between 2006 and 2008, 3 guidelines that focused on advice for patients with a dilating 
ascending aorta in combination with BAV or AR were published: (1) the 2006 ACC/AHA 
guidelines for the management of valvular heart disease (Bonow et al., 2006); (2) the 2007 
European Society of Cardiology (ESC) guidelines on the management of valvular heart 
disease (Vahanian et al., 2007); and (3) the 2008 ACC/AHA guidelines for managing adults 
with congenital heart disease (Warnes et al., 2008). All give practically the same 
recommendations as the following guidelines. 
Management Guidelines for Patients with Bicuspid Aortic Valve with Dilated Ascending 
Aorta proposed by the 2008 ACC/AHA guidelines (Bonow et al., 2008). 
Class I 
1. Patients with known bicuspid aortic valves should undergo an initial transthoracic 
echocardiogram to assess the diameters of the aortic root and ascending aorta. (Level of 
Evidence: B) 
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2. Cardiac magnetic resonance imaging or cardiac computed tomography is indicated in 
patients with bicuspid aortic valves when morphology of the aortic root or ascending 
aorta cannot be assessed accurately by echocardiography. (Level of Evidence: C) 
3. Patients with bicuspid aortic valves and dilatation of the aortic root or ascending aorta 
(diameter greater than 4.0 cm*) should undergo serial evaluation of aortic 
root/ascending aorta size and morphology by echocardiography, cardiac magnetic 
resonance, or computed tomography on a yearly basis. (Level of Evidence: C) 
4. Surgery to repair the aortic root or replace the ascending aorta is indicated in patients 
with bicuspid aortic valves if the diameter of the aortic root or ascending aorta is 
greater than 5.0 cm* or if the rate of increase in diameter is 0.5 cm per year or more. 
(Level of evidence: C) 
5. In patients with bicuspid valves undergoing AVR because of severe AS or AR repair of 
the aortic root or replacement of the ascending aorta is indicated if the diameter of the 
aortic root or ascending aorta is greater than 4.5 cm*. (Level of evidence: C) 
Class IIa 
6. It is reasonable to give beta-adrenergic blocking agents to patients with bicuspid valves 
and dilated aortic roots (diameter greater than 4.0 cm*) who are not candidates for 
surgical correction and who do not have moderate to severe AR. (Level of Evidence: C) 
7. Cardiac magnetic resonance imaging or cardiac computed tomography is reasonable in 
patients with bicuspid aortic valves when aortic root dilatation is detected by 
echocardiography to further quantify severity of dilatation and involvement of the 
ascending aorta. (Level of Evidence: B). 
The recent 2010 ACC Foundation/AHA guidelines (Hiratzka et al., 2010) have provided 
adjusted indications for prophylactic surgery of asymptomatic patients with ascending 
aortic anneurysm. 
Class I 
Patients with Marfan syndrome or other genetically mediated disorders (vascular 
Ehlers-Danlos syndrome, Turner syndrome, bicuspid aortic valve, or familial thoracic 
aortic aneurysm and dissection) should undergo elective operation at smaller diameters 
(4.0 to 5.0 cm depending on the condition) to avoid acute dissection or rupture. (Level 
of Evidence: C) 
Class IIa 
Elective aortic replacement is reasonable for patients with Marfan syndrome, other 
genetic diseases, or bicuspid aortic valves, when the ratio of maximal ascending or 
aortic root area (πr2) in cm2 divided by the patient’s height in meters exceeds 10. (Level 
of Evidence: C) 
More recently, Svensson et al. (2011) proposed that an aortic size larger than 4.5 cm or aortic 
cross-sectional area/height ratio greater than 8 to 10 should be considered triggers for 
concurrent aortic repair, because there is no added risk, and late survival is better. 
3.3 Thoracic endovascular aneurysm repair (TEVAR) 
TEVAR is a minimally invasive method for managing descending aortic aneurysms in the 
acute and chronic settings (Dake et al., 1994; Dake et al., 1999) and is becoming more 
frequently used (Gopaldas et al., 2010; Coady et al., 2010). TEVAR has been suggested as an 
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alternative, although controversial, approach for the elderly with comorbidities because of 
the high risk of open repair (Tadros et al., 2009). Nevertheless, TEVAR is not currently a 
definitive approach for managing ascending aortic dilatation with BAV because the contour 
of the ascending aorta is complex and has inadequate landing zones to anchor the stent 
grafts, especially when dilatation involves the aortic annulus and extends into the arch 
(Tadros et al., 2009). Whether future developments in these techniques may render them 
more widely applicable as therapy for ascending aortic aortopathy is still unknown (Atkins 
et al., 2006; Vallely et al., 2008). On the other hand, the data are limited on TEVAR in 
patients with connective tissue disease, as well as on continued aortic expansion and higher 
reintervention rates (Geisbusch et al., 2008). Furthermore, patients with BAV aortopathy 
typically need intervention at a younger age, and currently TEVAR has not been shown to 
provide as durable long-term results as does open repair (Tadros et al., 2009). 
4. Conclusion 
BAV is the most common form of congenital heart defect. Although BAV can be found in 
isolation because of a disorder of valvulogenesis, it is also represented as coexistent aspects 
of a genetic disorder of aortopathy, and is most frequently associated with dilatation of the 
proximal ascending aorta. With or without intervention, patients with BAV require 
continued surveillance. Because BAV is a disease of both valvular pathology and 
aortopathy, surgical decision making is more complicated than previously believed. There 
are several surgical options available to patients with BAV. New surgical techniques have 
been developed, especially for valve repair and transcatheter aortic valve implantation. The 
surgical intervention option should be individualized to each patient, depending on the 
surgical experience and skill of the surgeon. If aortic valve repair for valvular regurgitation 
or an aortic valve sparing procedure is to be considered, patients should be referred to 
experienced centers where there is both interest and experience with surgical options 
available for these patients. Compared with trileaflet aortic valve patients, BAV disease 
patients have a connective tissue disorder leading to a higher prevalence and faster yearly 
growth rate of the ascending aorta, which increases the risk of dissection or rupture at a 
younger age. Thus, ascending aortic dilatation associated with BAV warrants frequent 
monitoring, with possible early prophylactic intervention to prevent dissection or rupture. 
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